Eisai Co., Ltd.

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: JP3160400002
JPY
4,605.00
-84 (-1.79%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Comparison
Company
Score
Quality
Valuation
Financial
Technical
Astellas Pharma, Inc.
Chugai Pharmaceutical Co., Ltd.
Shionogi & Co., Ltd.
Otsuka Holdings Co., Ltd.
Ono Pharmaceutical Co., Ltd.
Daiichi Sankyo Co., Ltd.
Eisai Co., Ltd.
Kyowa Kirin Co., Ltd.
Takeda Pharmaceutical Co., Ltd.
Kobayashi Pharmaceutical Co., Ltd.
Taisho Pharmaceutical Holdings Co., Ltd.
Why is Eisai Co., Ltd. ?
1
Company's ability to service its debt is strong with a healthy EBIT to Interest (avg) ratio of 21.93
2
Poor long term growth as Operating profit has grown by an annual rate -19.80% of over the last 5 years
  • INTEREST(HY) At JPY 2,006 MM has Grown at 28.59%
  • NET PROFIT(HY) At JPY 15,424 MM has Grown at -35.44%
  • DEBT-EQUITY RATIO (HY) Highest at -5.61 %
3
With ROE of 5.71%, it has a very attractive valuation with a 1.39 Price to Book Value
  • The stock is trading at a premium compared to its peers' average historical valuations
  • Over the past year, while the stock has generated a return of 4.23%, its profits have risen by 9.8% ; the PEG ratio of the company is 2.1
  • At the current price, the company has a high dividend yield of 0
4
Underperformed the market in the last 1 year
  • The stock has generated a return of 4.23% in the last 1 year, much lower than market (Japan Nikkei 225) returns of 28.54%
stock-recommendationReal-Time Research Report
Verdict Report
How much should you hold?
  1. Overall Portfolio exposure to Eisai Co., Ltd. should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Eisai Co., Ltd. for you?

Low Risk, High Return

Absolute
Risk Adjusted
Volatility
Eisai Co., Ltd.
4.23%
182.37
30.82%
Japan Nikkei 225
28.54%
1.11
25.75%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
2.56%
EBIT Growth (5y)
-19.80%
EBIT to Interest (avg)
21.93
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.09
Sales to Capital Employed (avg)
0.75
Tax Ratio
21.30%
Dividend Payout Ratio
97.70%
Pledged Shares
0
Institutional Holding
0.09%
ROCE (avg)
6.79%
ROE (avg)
5.99%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
24
Industry P/E
Price to Book Value
1.39
EV to EBIT
26.57
EV to EBITDA
13.46
EV to Capital Employed
1.43
EV to Sales
1.38
PEG Ratio
2.09
Dividend Yield
0.01%
ROCE (Latest)
5.37%
ROE (Latest)
5.71%
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Mildly Bullish
Dow Theory
Mildly Bearish
No Trend
OBV
Mildly Bullish
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

5What is working for the Company
OPERATING CASH FLOW(Y)

Highest at JPY 39,792 MM

RAW MATERIAL COST(Y)

Fallen by -0.01% (YoY

OPERATING PROFIT MARGIN(Q)

Highest at 15.19 %

-13What is not working for the Company
INTEREST(HY)

At JPY 2,006 MM has Grown at 28.59%

NET PROFIT(HY)

At JPY 15,424 MM has Grown at -35.44%

DEBT-EQUITY RATIO (HY)

Highest at -5.61 %

INVENTORY TURNOVER RATIO(HY)

Lowest at 0.82%

Here's what is working for Eisai Co., Ltd.
Operating Cash Flow
Highest at JPY 39,792 MM and Grown
In each year in the last three years
MOJO Watch
The company has generated higher cash revenues from business operations

Operating Cash Flows (JPY MM)

Operating Profit Margin
Highest at 15.19 %
in the last five periods
MOJO Watch
Company's profit margin has improved

Operating Profit to Sales

Raw Material Cost
Fallen by -0.01% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Eisai Co., Ltd.
Interest
At JPY 2,006 MM has Grown at 28.59%
over previous Semi-Annual period
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (JPY MM)

Net Profit
At JPY 15,424 MM has Grown at -35.44%
Year on Year (YoY)
MOJO Watch
Near term Net Profit trend is negative

Net Profit (JPY MM)

Debt-Equity Ratio
Highest at -5.61 % and Grown
In each half year in the last five Semi-Annual periods
MOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio

Inventory Turnover Ratio
Lowest at 0.82%
in the last five Semi-Annual periods
MOJO Watch
Company's pace of selling inventory has slowed

Inventory Turnover Ratio